Multiple predicted immune and inflammatory pathway proteins

Multiple predicted immune and inflammatory pathway proteins is a collective term used in bioinformatics and proteomic research to describe a set of proteins associated with immune and inflammatory responses, rather than a single, specific therapeutic target (Source: Nature Communications, 2021). This designation often arises from high-throughput screening or genome-wide association studies where multiple proteins—such as cytokines, chemokines, and signaling kinases—are found to be co-regulated or statistically linked to a disease state. Because it represents a functional group rather than a single molecular entity, it lacks a specific biochemical structure, a defined binding pocket, or a unique pharmacological profile. In the context of drug development, while these pathways are essential for understanding the pathophysiology of conditions like rheumatoid arthritis or sepsis, therapeutic intervention requires the identification of specific, druggable nodes within the group. As an aggregate category, it cannot be targeted by a single drug with a uniform mechanism of action, making it an incorrect entry for a database focused on individual molecular targets. This term serves as a systems-biology placeholder for a complex network of interactions that drive inflammatory processes (Source: Frontiers in Immunology, 2022).

Other names

Immune and inflammatory pathway proteinsInflammatory pathway proteins

Not applicable as this refers to a broad group of proteins rather than a single, specific therapeutic target.